Automate Your Wheel Strategy on MCK
With Tiblio's Option Bot, you can configure your own wheel strategy including MCK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MCK
- Rev/Share 3023.1785
- Book/Share -6.9095
- PB -54.568
- Debt/Equity -5.0498
- CurrentRatio 0.8829
- ROIC 0.1716
- MktCap 107421245703.0
- FreeCF/Share 45.9888
- PFCF 18.7015
- PE 33.9239
- Debt/Assets 0.1222
- DivYield 0.0034
- ROE -1.2479
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | MCK | Mizuho | -- | Neutral | -- | $630 | Dec. 4, 2024 |
| Downgrade | MCK | Robert W. Baird | Outperform | Neutral | $603 | $531 | Sept. 24, 2024 |
| Reiterated | MCK | Leerink Partners | -- | Outperform | $670 | $665 | Sept. 5, 2024 |
News
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
4 Value Stocks With Strong Interest Coverage as Markets Rebound
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
Read More
McKesson Corporation (MCK) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 10, 2025 by: Seeking Alpha
Sentiment: Neutral
McKesson Corporation ( MCK ) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM EST Company Participants Britt Vitalone - Executive VP & CFO Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thank you for coming to the UBS Healthcare Conference.
Read More
Here is Why Growth Investors Should Buy McKesson (MCK) Now
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
Read More
Will Strong Segmental Performance Drive MCK's Top Line in Q2?
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.
Read More
Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Published: October 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Read More
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) reached $801.67 at the closing of the latest trading day, reflecting a +1.1% change compared to its last close.
Read More
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here's Why McKesson (MCK) is a Strong Momentum Stock
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
Read More
How to trade the health care break out
Published: October 06, 2025 by: CNBC Television
Sentiment: Positive
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
Read More
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Drug distributor McKesson to restructure segments to focus on high-margin businesses
Published: September 18, 2025 by: Reuters
Sentiment: Positive
McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
Read More
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Read More
Here's Why McKesson (MCK) is a Strong Value Stock
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
Read More
Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
DIS, BJ, RL, and MCK stand out with strong interest coverage ratios, making them attractive picks in a volatile market.
Read More
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
About McKesson Corporation (MCK)
- IPO Date 1994-11-10
- Website https://www.mckesson.com
- Industry Medical - Distribution
- CEO Brian S. Tyler
- Employees 44000